Product Development Process: Idea to Commercial Production

The product development process turns a commercial idea into a formula, package and repeatable production system that can be sold under a brand. It begins before the first laboratory sample and continues beyond the first manufacturing run. Customer definition, pricing, claims, testing, packaging, documentation and launch planning are all part of the pathway.

A common founder mistake is to treat formulation as the entire project. The formula is central, but it cannot succeed commercially if the packaging is unsuitable, the claims lack support, the unit economics do not work or production cannot be repeated consistently.

This guide follows the complete journey from idea to commercial production for Australian skincare, cosmetics, haircare, supplement and formulated-product brands.

Phase 1: Define the commercial concept

Identify the customer and problem

Define who will use the product, the situation in which they will use it, the result they expect and the alternatives they currently purchase. Broad demographic descriptions are less useful than a clear account of the routine or unmet need.

State the product promise

Write one sentence explaining the format, customer and point of difference. This becomes a filter for later decisions. Ingredients, packaging and claims should support the promise rather than create unrelated features.

Map the range

List every product planned over the next 12 to 24 months and rank them. Discuss the whole range with the manufacturer even when only one product will move first. Shared packaging, ingredients, flavours, fragrances or processes may affect the recommended sequence.

Phase 2: Build the commercial model

Choose the sales channel

Direct-to-consumer, wholesale, retail, practitioner, distributor and export channels have different margin and documentation needs. The channel influences pack size, retail price, target cost and production volume.

Set price and cost expectations

Work backwards from the intended retail price through wholesale or distributor margins, discounts, freight, fulfilment, returns, customer acquisition and overheads. The manufacturing target must support the whole business model.

Estimate volume

Provide a realistic first order and annual forecast. Formula batch minimums, raw-material packs and packaging minimums may be different. A forecast supported by launch channels is more useful than an aspirational figure.

Prepare the total budget

Allow for development, sample rounds, testing, packaging, design, artwork, production, freight and marketing. Confirm which services are included and which require separate quotations.

Phase 3: Select the development pathway

Private label

An established formula can offer a more defined starting point and may suit a brand prioritising timing, simplicity or validation. Customisation and ownership terms vary.

Semi-custom development

An existing technical foundation is modified within an agreed scope. Even minor changes require review because fragrance, colour or supporting ingredients can affect preservation, viscosity, flavour or stability.

Custom formulation

A unique formula is developed around the brand brief. This usually requires more technical work, samples, documentation, scale-up and project-specific testing.

Formula transfer or reformulation

An existing formula may be transferred, improved or adapted if the brand has the right to use it and sufficient documentation is available. The receiving manufacturer still needs to assess materials, equipment, process and packaging.

Explore private label skin care, custom cosmetic formulation and supplement new product development.

Phase 4: Complete the technical brief

The brief should identify the product format, target customer, sensory profile, ingredients, exclusions, claims, fill size, packaging, markets, quantity, target cost, budget and timing.

For cosmetics, sensory requirements may cover colour, fragrance, viscosity, spread, lather, rinse, absorption and finish. For powdered products, consider flavour, sweetness, texture, dispersion, preparation and serving format.

Separate non-negotiables from preferences. This allows the development team to manage technical trade-offs without repeatedly seeking approval for minor decisions.

Phase 5: Assess feasibility

The formulator and manufacturer review whether the requested format, ingredients, claims, cost, packaging and volume can work together. Equipment, raw-material availability, batch sizes, filling and quality requirements are considered.

Feasibility is both technical and commercial. A formula can be physically possible but unsuitable for the target price or first-order quantity. The purpose of assessment is to identify those conflicts before substantial development spending.

Phase 6: Formulate and sample

The formulator prepares coded samples against the approved brief. The brand assesses each version under appropriate conditions and provides consolidated, specific feedback.

Useful feedback describes viscosity, fragrance strength, colour, lather, absorption, flavour, sweetness, aftertaste or another observable characteristic. Vague statements such as “make it more premium” should be translated into the experience that needs to change.

Revisions should move the sample toward the agreed brief. A new format, customer, ingredient strategy or price position may require re-scoping rather than another included revision. Read how sampling and formula revisions work.

Phase 7: Develop packaging alongside the formula

Packaging affects dispensing, protection, filling, label space, transport and customer experience. The formula and component should be developed as one system.

Confirm material, dimensions, closure, pump output, decoration, labels, minimums, lead times and filling compatibility. Obtain samples before bulk ordering and build an appropriate production contingency.

Custom components can create differentiation but add tooling, proofs, higher minimums and longer lead times. Stock components may simplify the first launch without preventing a future upgrade.

Phase 8: Confirm claims and regulatory responsibilities

Claims should be drafted before formula approval and artwork. They can influence ingredients, evidence, product category and market requirements. Review the exact wording across packaging, product pages, advertisements and retailer content.

Define who is responsible for ingredient review, label content, evidence, market notifications, listings or submissions where applicable. A manufacturer, laboratory report or ingredient supplier does not automatically assume responsibility for every representation made by the brand.

Phase 9: Create the testing plan

Testing depends on the formula, category, packaging, use, claims and market. Relevant work may include stability, packaging compatibility, microbiological or preservative efficacy testing, analytical assessment and claim substantiation.

The protocol should identify the sample, package, conditions, time points, measurements and acceptance criteria. Some work requires production-representative samples or final components and cannot be completed meaningfully using an early concept sample.

Phase 10: Approve the product and specifications

The approved formula, method, reference sample and finished-product specifications should align. Relevant specifications may include appearance, colour, odour, flavour, pH, viscosity, density or other product-specific measures.

Record the approval using the correct sample code and date. Avoid relying on an unlabelled jar or informal message as the commercial standard.

Phase 11: Finalise artwork and documentation

Artwork should use the current formula information, directions, warnings, claims, fill declaration, company details and component dimensions. Complete copy, design, technical review, corrections, print proof and final approval through controlled versions.

Maintain one approved source for formulas, specifications, artwork and test reports. Files called “final,” “final new” and “final final” create avoidable production risk.

Phase 12: Prepare raw materials and components

The manufacturer confirms approved materials, quantities, supplier lead times, packaging delivery and required documents. Substitutions need technical review because apparently similar materials can behave differently.

Production readiness should be checked as a complete system. One missing label, pump or ingredient can prevent the scheduled batch from proceeding.

Phase 13: Complete manufacturing scale-up

Scale-up translates the laboratory method into commercial equipment. Mixing, heating, cooling, shear, addition order, batch depth, transfer and filling can all affect the outcome.

The first-scale process should be documented and assessed against the approved specification. Any technical adjustment needs controlled review. Read what happens during manufacturing scale-up.

Phase 14: Manufacture the commercial batch

The production team weighs and verifies materials, follows the approved method, records processing information and performs relevant in-process checks. Expected yield accounts for normal losses in vessels, hoses, transfers and filling.

Production is not the right stage for uncontrolled formula development. Changes should be assessed and documented rather than made informally to rescue the schedule.

Phase 15: Fill, finish and release

The bulk product is filled into approved components, closed, labelled or decorated, batch coded and assembled as agreed. Fill accuracy, closure, appearance and other relevant checks are completed.

Production and quality records are reviewed against the applicable release process. Allow time after filling for review, packing and freight rather than scheduling customer delivery for the moment the line stops.

Phase 16: Launch with approved information

Product pages, retailer listings, advertisements, FAQs and customer-service information should match the approved pack and claims. Education can explain the format, use, sensory experience or manufacturing story without exaggeration.

Monitor feedback, returns, packaging performance, support questions and sales velocity. Separate individual preference from recurring technical patterns.

Phase 17: Plan the reorder

Set a reorder trigger based on finished inventory, sales velocity, raw-material lead times, packaging stock and manufacturing capacity. Waiting until stock is nearly exhausted can create avoidable gaps.

Record learning from the first run and decide whether formula, pack, quantity or process improvements are justified before confirming the next batch.

Critical decision gates

1. Commercial concept and budget approved.
2. Development pathway and scope accepted.
3. Formula and sensory experience approved.
4. Packaging and filling pathway confirmed.
5. Testing and claim responsibilities documented.
6. Artwork and specifications approved.
7. Materials and components production-ready.
8. Scale-up or commercial process accepted.
9. Finished batch reviewed and released.

Decision gates prevent the brand from committing heavily to packaging, printing or production while important upstream work is still changing.

Who should manage the project?

The brand should nominate one internal project owner who can coordinate decisions, consolidate stakeholder feedback and maintain the current files. The manufacturer should identify the appropriate commercial and technical contacts. Clear ownership prevents important questions from becoming lost across email, calls and informal messages.

A practical project tracker should show each deliverable, responsible party, approval status, dependency and due date. Formula samples, packaging samples, test submissions and artwork should be identified by code or version. The tracker does not replace formal specifications or manufacturing records; it connects the commercial workflow so everyone knows what is waiting and why.

When the range contains several products, manage each product separately while keeping shared decisions visible. A delayed fragrance, pump or claim should not create confusion about the status of unrelated products.

Common causes of failure

• an incomplete or changing brief;
• too many products launched at once;
• no realistic retail and margin model;
• packaging ordered before technical review;
• claims added after formula approval;
• testing considered too late;
• conflicting sample feedback;
• an announced launch date driving unsafe shortcuts;
• formula ownership or transfer rights left unclear;
• no reorder plan after first production.

See common product development mistakes and how to avoid them.

Frequently asked questions

What is the first step in product development?

Define the customer, problem, format, channel, price, quantity and commercial reason for the product before selecting ingredients.

How long does development take?

Timing varies with the pathway, sample rounds, testing, packaging, materials, approvals and production capacity. Use the manufacturing timelines guide for planning.

Can a startup develop a custom product?

Yes, when the budget, brief, order quantity and launch plan align with a workable development and manufacturing pathway.

When should packaging be ordered?

Research it early, but commit to bulk components only after formula, filling, compatibility, minimums and artwork requirements are assessed.

Does an approved sample mean production can start?

Not necessarily. Specifications, testing, packaging, artwork, materials, scale-up and commercial approvals may still be required.

Who owns a custom formula?

Ownership depends on the written agreement. Confirm licensing, assignment, use and transfer rights before development begins.

Develop with Australian Private Label

Australian Private Label supports product scoping, private label products, custom formulation, testing and commercial manufacturing. Each project is assessed according to its category, formula, packaging, claims, quantity and business plan.

Important: This article provides general commercial information and is not legal, regulatory or technical advice for a specific product. Development, testing, ownership, claims, manufacturing and release requirements must be confirmed for each project.